Ran Peng

1.9k total citations · 2 hit papers
28 papers, 1.1k citations indexed

About

Ran Peng is a scholar working on Molecular Biology, Surgery and Pharmacology. According to data from OpenAlex, Ran Peng has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Surgery and 5 papers in Pharmacology. Recurrent topics in Ran Peng's work include Gut microbiota and health (8 papers), Berberine and alkaloids research (4 papers) and Genomics and Phylogenetic Studies (4 papers). Ran Peng is often cited by papers focused on Gut microbiota and health (8 papers), Berberine and alkaloids research (4 papers) and Genomics and Phylogenetic Studies (4 papers). Ran Peng collaborates with scholars based in China, France and United Kingdom. Ran Peng's co-authors include Shurong Ma, Li‐Bin Pan, Jian‐Dong Jiang, Hang Yu, Jinbo Yu, Pei Han, Zhenxiong Zhao, Zhengwei Zhang, Jie Fu and Lin Cong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Ran Peng

26 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota

2021 240 citations Yan Wang, Qian Tong et al. Signal Transduction and Targeted Therapy profile →
Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota

2022 120 citations Shurong Ma, Qian Tong et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ran Peng China	12	659	192	167	159	152	28	1.1k
Shurong Ma China	18	782 1.2×	261 1.4×	226 1.4×	189 1.2×	164 1.1×	45	1.3k
Li‐Bin Pan China	15	639 1.0×	170 0.9×	190 1.1×	184 1.2×	193 1.3×	30	1.1k
Hang Yu China	17	628 1.0×	162 0.8×	161 1.0×	187 1.2×	141 0.9×	44	1.1k
Syed Minhaj Uddin Ahmed Bangladesh	4	833 1.3×	97 0.5×	154 0.9×	141 0.9×	65 0.4×	10	1.5k
Yan Guo China	22	652 1.0×	79 0.4×	77 0.5×	177 1.1×	80 0.5×	78	1.7k
Songwei Yang China	18	683 1.0×	67 0.3×	154 0.9×	132 0.8×	85 0.6×	42	1.4k
Emre Karakuş Türkiye	23	357 0.5×	134 0.7×	208 1.2×	121 0.8×	35 0.2×	59	1.4k
Tianlong Liu China	23	502 0.8×	138 0.7×	122 0.7×	74 0.5×	35 0.2×	66	1.2k
Larissa Staurengo‐Ferrari Brazil	22	525 0.8×	165 0.9×	221 1.3×	306 1.9×	23 0.2×	53	1.5k
Zhou Lan China	19	498 0.8×	79 0.4×	181 1.1×	174 1.1×	26 0.2×	51	1.1k

Countries citing papers authored by Ran Peng

Since Specialization

Citations

This map shows the geographic impact of Ran Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Peng more than expected).

Fields of papers citing papers by Ran Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Peng. The network helps show where Ran Peng may publish in the future.

Co-authorship network of co-authors of Ran Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Peng. A scholar is included among the top collaborators of Ran Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Peng. Ran Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peng, Ran, Zhenyu He, Yingxin Pang, et al.. (2025). Targeted regulatory strategies for VCAM-1 in multisystem diseases. European Journal of Medicinal Chemistry Reports. 15. 100300–100300.

Peng, Ran, et al.. (2025). Predicting recurrence of non-muscle invasive bladder urothelial carcinoma: predictive value of the optimal cut-off value of Ki67. Frontiers in Oncology. 14. 1522009–1522009. 2 indexed citations

Ma, Shurong, Qian Tong, Yuan Lin, et al.. (2022). Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota. Signal Transduction and Targeted Therapy. 7(1). 207–207. 120 indexed citations breakdown →

Peng, Ran, Pei Han, Jie Fu, et al.. (2022). Esterases From Bifidobacteria Exhibit the Conversion of Albiflorin in Gut Microbiota. Frontiers in Microbiology. 13. 880118–880118. 11 indexed citations

Wang, Yan, Qian Tong, Shurong Ma, et al.. (2021). Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota. Signal Transduction and Targeted Therapy. 6(1). 77–77. 240 indexed citations breakdown →

Han, Pei, Lisha Li, Zixi Wang, et al.. (2021). Multi-Omics Analysis Provides Insight into the Possible Molecular Mechanism of Hay Fever Based on Gut Microbiota. Engineering. 15. 115–125. 3 indexed citations

Zhao, Zhe, Fangyuan Li, Jingwen Ning, et al.. (2021). Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis. Acta Pharmaceutica Sinica B. 11(9). 2859–2879. 86 indexed citations

Zhang, Zhengwei, Lin Cong, Ran Peng, et al.. (2020). Transformation of berberine to its demethylated metabolites by the CYP51 enzyme in the gut microbiota. Journal of Pharmaceutical Analysis. 11(5). 628–637. 38 indexed citations

Yu, Jinbo, Zhenxiong Zhao, Ran Peng, et al.. (2019). Gut Microbiota-Based Pharmacokinetics and the Antidepressant Mechanism of Paeoniflorin. Frontiers in Pharmacology. 10. 268–268. 77 indexed citations

10.

Pan, Li‐Bin, Pei Han, Shurong Ma, et al.. (2019). Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia. Acta Pharmaceutica Sinica B. 10(2). 249–261. 142 indexed citations

11.

Ma, Shurong, Qian Tong, Zhenxiong Zhao, et al.. (2019). Determination of berberine-upregulated endogenous short-chain fatty acids through derivatization by 2-bromoacetophenone. Analytical and Bioanalytical Chemistry. 411(14). 3191–3207. 25 indexed citations

12.

Peng, Ran, Ye Wang, Zhifeng Li, et al.. (2018). CRISPR/dCas9-mediated transcriptional improvement of the biosynthetic gene cluster for the epothilone production in Myxococcus xanthus. Microbial Cell Factories. 17(1). 15–15. 50 indexed citations

13.

Zhao, Zhenxiong, Jie Fu, Shurong Ma, et al.. (2018). Gut-brain axis metabolic pathway regulates antidepressant efficacy of albiflorin. Theranostics. 8(21). 5945–5959. 108 indexed citations

14.

Cui, Xiaoqiang, Zheng Zhang, Ran Peng, et al.. (2017). A bacterial negative transcription regulator binding on an inverted repeat in the promoter for epothilone biosynthesis. Microbial Cell Factories. 16(1). 92–92. 9 indexed citations

15.

Peng, Ran, et al.. (2017). Error-prone DnaE2 Balances the Genome Mutation Rates in Myxococcus xanthus DK1622. Frontiers in Microbiology. 8. 122–122. 10 indexed citations

16.

Zhu, Liang, et al.. (2016). Surgical monotherapy may be a suitable therapeutic strategy for advanced collecting (Bellini) duct carcinoma: A case report and literature review. Experimental and Therapeutic Medicine. 12(2). 1181–1184. 7 indexed citations

17.

Bao, Lidao, et al.. (2015). Correlation between the decrease of cholesterol efflux from macrophages in patients with type II diabetes mellitus and down-regulated CYP7A1 expression. Genetics and Molecular Research. 14(3). 8716–8724. 11 indexed citations

18.

Xiong, Wei, Ran Peng, Liang Zhu, & Zhaohui Zhong. (2015). Bladder exstrophy-epispadias complex with adenocarcinoma in an adult patient: A case report. Experimental and Therapeutic Medicine. 10(6). 2194–2196. 8 indexed citations

19.

Peng, Ran, et al.. (2015). Hemodynamic changes of unexplained syncope patients in head-up tilt test. Genetics and Molecular Research. 14(1). 626–633. 4 indexed citations

20.

Han, Kuihua, Li Z, Ran Peng, et al.. (2013). Extraordinary expansion of a Sorangium cellulosum genome from an alkaline milieu. Scientific Reports. 3(1). 2101–2101. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact